An allergy practice generates more measurable numbers in twenty minutes than most specialties produce in a month.

The RealityA photograph of a grid is not a measurement

⚠️

The Problem

The most quantitative data in the practice, scanned.

Millimetre measurements filed as an image, unsearchable, uncomparable, and detached from the antigen list.

🔧

The Solution

Capture the result, not the sheet.

Antigen, measurement, control comparison and grade as discrete fields, with the scale in use recorded.

✅

The Resolution

A series a clinician can read.

Year-on-year comparison, defensible billing, and a record that survives a change of reader.

Grading scales are not standardised, and that is the argument

This is the fact that changes how you should think about the problem, and it is not widely discussed.

FDA-approved allergenic extract labelling carries the grading instructions, and different manufacturers use dimensionally different scales. One FDA-approved directions-for-use document grades percutaneous tests by comparison — erythema greater than control but smaller than a nickel, erythema greater than a nickel with no wheal, wheal and erythema without pseudopods, wheal and erythema with pseudopods — and instructs that the test be read in 15 minutes, measuring both wheal size and erythema.

Another manufacturer’s labelling, published through NIH’s DailyMed, grades using millimetre bands for erythema and wheal plus a summed erythema diameter, and instructs that test sites be examined at 15 and 30 minutes, with the smallest reaction considered positive being erythema with a central papule at least 5 mm in diameter.

Those are not the same scale expressed differently. They measure different things. A grade of “3+” means one thing under one label and something else under another, which means a grade recorded without the scale it came from is ambiguous the moment the practice changes supplier.

What the literature uses for wheal measurement

For the underlying measurement there is a reasonably settled convention, which helps.

A review in Clinical and Translational Allergy describes the wheal as the mean value of the longest and the midpoint orthogonal diameter in millimetres, and notes that a wheal average diameter of 3 mm is generally considered a positive skin prick test cut-off value, with histamine at 10 mg/ml as the positive control.

Two diameters per test, then, plus the controls. That is four to six numbers per antigen, times the number of antigens, and it is exactly the kind of data that is trivial to hold in a structured field and painful to extract from a photograph.

Unit of service, and why the count has to be discrete

The billing side reinforces the same design decision, which is convenient.

CMS contractor guidance is unambiguous about the unit. One Medicare billing and coding guideline for allergy testing states plainly: enter 1 unit for each test performed, and gives the example that if 18 scratch tests are done, the code is reported with 18 like services. Another states that the unit of service to report is the number of separate tests, and that Part B providers indicate the number of tests, one for each antigen, on the claim.

So the claim is a count of antigens tested. A practice that scans a grid and types a number into the claim has two records of that count and no automatic agreement between them. Contractor guidance also states that the selection of antigens should be individualised and based on specific details obtained and documented within the history and physical examination, and that the number of antigens should be individualised for each patient based on history and environmental exposure — which is a documentation requirement attached directly to the number you billed.

The retesting interval, which the record has to support

There is a specific expectation here that catches practices whose records cannot show what was tested before.

A Medicare local coverage determination on allergy skin testing states that retesting with the same antigens should rarely be necessary within a three-year period, and that if extensive repeat testing is required within three years, those circumstances must be clearly documented in the medical record, including an explanation of why the original testing is unacceptable.

That obligation is effectively impossible to meet from scanned grids at any scale. Answering “was this antigen tested in the last three years, and what was the result” requires the prior results to be data. Practices that hold them as images answer the question by having someone open files, which does not happen reliably and does not happen at all when the original reader has left. This is one of the clearest cases we see where a documentation format has a direct compliance consequence, and it is worth addressing inside EHR workflow optimization rather than treating it as a filing preference.

Extract standardisation and what the antigen field should hold

One more reason the antigen has to be a coded field rather than free text.

FDA maintains reference standards for a defined set of standardised allergenic extracts, against which manufacturers compare their product for potency; extracts with no US reference standard are called non-standardised. The standardised list runs to 19 items across epidermals, insects, pollens and venoms.

The practical consequence is that “cat” is not a sufficient antigen record, because FDA standardises cat hair and cat pelt separately. Free text loses that distinction and a coded list preserves it. The same logic applies across the grass pollens, where several are separately standardised and a clinician a year later needs to know which one was tested.

What to capture, concretely

The minimum useful structure, derived from the above.

• Antigen as a coded item. Cat hair and cat pelt are different entries.
• Two diameters, in millimetres. Longest and midpoint orthogonal.
• Both controls, every panel. The grade is a comparison.
• The scale and the supplier. A grade without its labelling is ambiguous.

Qventive provides allergy skin test EHR documentation help for medical practices in New Jersey, normally as part of IT support for allergy immunology practices rather than as an isolated build.

Template and interface work of this kind runs through EHR template development and allergy and immunology EHR and IT support; wherever results leave the practice, that path belongs in your HIPAA risk analysis.

Skin test documentation: common questions